Nanospectra Biosciences, Inc.

FDA Regulatory Profile

Nanospectra Biosciences, Inc. appears in FDA public data with 0 recalls, 2 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on July 2, 2025.

Summary

Total Recalls
0
510(k) Clearances
2
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K243701AuroLase® SystemJuly 2, 2025
K202953Aurolase Therapy, Laser Delivery Device (LDD)October 3, 2022